日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Differential Regulation of the Three Eukaryotic mRNA Translation Initiation Factor (eIF) 4Gs by the Proteasome

蛋白酶体对三种真核 mRNA 翻译起始因子 (eIF) 4G 的差异调控

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2019.00254
Amandine Alard, Catherine Marboeuf, Bertrand Fabre, Christine Jean, Yvan Martineau, Frédéric Lopez, Patrice Vende, Didier Poncet, Robert J Schneider, Corinne Bousquet, Stéphane Pyronnet
信号转导
发表日期：2019
文献求助 收藏

Should we screen for masked hypertension in patient with vascular disease?

对于患有血管疾病的患者，我们是否应该筛查隐匿性高血压？

期刊:Vascular Health and Risk Management
影响因子:2.8
doi:10.2147/vhrm.s9980
Delsart, Pascal; Marboeuf, Philippe; Delhaye, Cedric; Lemesle, Gilles; Mounier-Vehier, Claire
心血管
高血压
发表日期：2010
文献求助 收藏

NAD(P)H quinone-oxydoreductase 1 protects eukaryotic translation initiation factor 4GI from degradation by the proteasome

NAD(P)H醌氧化还原酶1保护真核翻译起始因子4GI免受蛋白酶体的降解。

期刊:Molecular and Cellular Biology
影响因子:2.7
doi:10.1128/MCB.00868-09
Alard, Amandine; Fabre, Bertrand; Anesia, Rodica; Marboeuf, Catherine; Pierre, Philippe; Susini, Christiane; Bousquet, Corinne; Pyronnet, Stéphane
发表日期：2010
文献求助 收藏

Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1

代谢综合征和侧支血管形成与已确诊冠状动脉闭塞患者相关：与高血糖、胰岛素抵抗、脂联素和纤溶酶原激活物抑制剂-1的关联

期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehn569
Mouquet, Frédéric; Cuilleret, François; Susen, Sophie; Sautière, Karine; Marboeuf, Philippe; Ennezat, Pierre Vladimir; McFadden, Eugène; Pigny, Pascal; Richard, Florence; Hennache, Bernadette; Vantyghem, Marie Christine; Bertrand, Michel; Dallongeville, Jean; Jude, Brigitte; Van Belle, Eric
代谢
代谢综合征
免疫/内分泌
发表日期：2009
文献求助 收藏